Research ExplorerPublicationsAdvances in liquid biopsy approaches for early detection and...

Advances in liquid biopsy approaches for early detection and monitoring of cancer

Standard

Advances in liquid biopsy approaches for early detection and monitoring of cancer. / Babayan, Anna; Pantel, Klaus.

In: GENOME MED, Vol. 10, No. 1, 20.03.2018, p. 21.

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Harvard

Babayan, A & Pantel, K 2018, 'Advances in liquid biopsy approaches for early detection and monitoring of cancer', GENOME MED, vol. 10, no. 1, pp. 21. https://doi.org/10.1186/s13073-018-0533-6

APA

Babayan, A., & Pantel, K. (2018). Advances in liquid biopsy approaches for early detection and monitoring of cancer. GENOME MED, 10(1), 21. https://doi.org/10.1186/s13073-018-0533-6

Vancouver

Babayan A, Pantel K. Advances in liquid biopsy approaches for early detection and monitoring of cancer. GENOME MED. 2018 Mar 20;10(1):21. https://doi.org/10.1186/s13073-018-0533-6

Bibtex

@article{8538553b4631474c9d3912bde81becea,
title = "Advances in liquid biopsy approaches for early detection and monitoring of cancer",
abstract = "Progress in sensitive analytical approaches has opened new avenues for the detection of cells or products such as circulating cell-free DNA released by tumors. These 'liquid biopsies' are being explored in clinical trials for early cancer detection, prediction of recurrent disease, and assessment of therapeutic resistance mechanisms.",
keywords = "Journal Article",
author = "Anna Babayan and Klaus Pantel",
note = "Editorial Material",
year = "2018",
month = mar,
day = "20",
doi = "10.1186/s13073-018-0533-6",
language = "English",
volume = "10",
pages = "21",
journal = "GENOME MED",
issn = "1756-994X",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Advances in liquid biopsy approaches for early detection and monitoring of cancer

AU - Babayan, Anna

AU - Pantel, Klaus

N1 - Editorial Material

PY - 2018/3/20

Y1 - 2018/3/20

N2 - Progress in sensitive analytical approaches has opened new avenues for the detection of cells or products such as circulating cell-free DNA released by tumors. These 'liquid biopsies' are being explored in clinical trials for early cancer detection, prediction of recurrent disease, and assessment of therapeutic resistance mechanisms.

AB - Progress in sensitive analytical approaches has opened new avenues for the detection of cells or products such as circulating cell-free DNA released by tumors. These 'liquid biopsies' are being explored in clinical trials for early cancer detection, prediction of recurrent disease, and assessment of therapeutic resistance mechanisms.

KW - Journal Article

U2 - 10.1186/s13073-018-0533-6

DO - 10.1186/s13073-018-0533-6

M3 - Other (editorial matter etc.)

C2 - 29558971

VL - 10

SP - 21

JO - GENOME MED

JF - GENOME MED

SN - 1756-994X

IS - 1

ER -